Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
After finishing at $116.79 in the prior trading day, Sarepta Therapeutics Inc (NASDAQ: SRPT) closed at $116.09, down -0.60%. In other words, the price has decreased by -$0.60 from its previous closing price. On the day, 0.64 million shares were traded. SRPT stock price reached its highest trading level at $118.2 during the session, while it also had its lowest trading level at $115.5.
Ratios:
Our goal is to gain a better understanding of SRPT by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.03 and its Current Ratio is at 3.84. In the meantime, Its Debt-to-Equity ratio is 1.14 whereas as Long-Term Debt/Eq ratio is at 1.07.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Needham on November 27, 2024, Reiterated its Buy rating but revised its target price to $202 from $205 previously.
On November 25, 2024, H.C. Wainwright started tracking the stock assigning a Sell rating and target price of $80.
Cantor Fitzgerald Upgraded its Neutral to Overweight on November 07, 2024, whereas the target price for the stock was revised from $152 to $167.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 12 ’24 when Wigzell Hans Lennart Rudolf sold 10,500 shares for $124.84 per share. The transaction valued at 1,310,820 led to the insider holds 22,840 shares of the business.
Wigzell Hans Lennart Rudolf bought 10,500 shares of SRPT for $1,310,400 on Dec 12 ’24. On Dec 05 ’24, another insider, Boor Kathryn Jean, who serves as the Director of the company, sold 1,636 shares for $125.55 each. As a result, the insider received 205,400 and left with 5,880 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SRPT now has a Market Capitalization of 11088870400 and an Enterprise Value of 11305345024. As of this moment, Sarepta’s Price-to-Earnings (P/E) ratio for their current fiscal year is 96.44, and their Forward P/E ratio for the next fiscal year is 9.91. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.76 while its Price-to-Book (P/B) ratio in mrq is 9.08. Its current Enterprise Value per Revenue stands at 6.892 whereas that against EBITDA is 94.474.
Stock Price History:
The Beta on a monthly basis for SRPT is 0.75, which has changed by -0.032744527 over the last 52 weeks, in comparison to a change of 0.24359846 over the same period for the S&P500. Over the past 52 weeks, SRPT has reached a high of $173.25, while it has fallen to a 52-week low of $102.15. The 50-Day Moving Average of the stock is -4.02%, while the 200-Day Moving Average is calculated to be -10.20%.
Shares Statistics:
The stock has traded on average 949.65K shares per day over the past 3-months and 894760 shares per day over the last 10 days, according to various share statistics. A total of 95.49M shares are outstanding, with a floating share count of 89.55M. Insiders hold about 6.25% of the company’s shares, while institutions hold 90.44% stake in the company. Shares short for SRPT as of 1735603200 were 5133485 with a Short Ratio of 5.41, compared to 1732838400 on 5816355. Therefore, it implies a Short% of Shares Outstanding of 5133485 and a Short% of Float of 5.6199998.
